
Avicanna Investor Relations Material
Latest events

Q4 2024
Avicanna
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Avicanna Inc
Access all reports
Avicanna Inc. is a Canadian international commercial-stage biopharmaceutical company focused on the development, advancement, and commercialization of evidence-based cannabinoid-based products. The company operates in the global medical and pharmaceutical market segments, leveraging its established scientific platform, including research and development (R&D) and clinical development. This platform has enabled Avicanna to launch over thirty proprietary products, along with a robust pharmaceutical pipeline aimed at addressing a range of medical conditions. Avicanna's business strategy encompasses active and commercial business pillars that include medical cannabis and wellness products, as well as a medical cannabis care portal. The company is headquartered in Toronto, Canada, and its shares are listed on the Toronto Stock Exchange.
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
AVCN
Country
🇨🇦 Canada